Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients Journal Article


Authors: Giralt, S.; Seifter, E.
Article Title: Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients
Abstract: With the advent new proteasome inhibitors (carfilzomib, ixazomib), new immune-modulatory drugs (pomalidomide), and new monoclonal antibodies (elotuzimab, daratumumab) as approved treatments for myeloma, the therapeutic landscape for this disease has changed. In this chapter, using a case-based approach, I will provide a personal guide of how I approach myeloma therapy in a transplant eligible patient in 2018. © 2018 by The American Society of Hematology. All rights reserved.
Journal Title: Hematology-American Society of Hematology Education Program
Volume: 2018
Issue: 1
ISSN: 1520-4391
Publisher: American Society of Hematology  
Date Published: 2018-11-30
Start Page: 103
End Page: 109
Language: English
DOI: 10.1182/asheducation-2018.1.103
PROVIDER: scopus c2 - 30504298
PMCID: PMC6245961
PUBMED: 30504298
DOI/URL:
Notes: Hematology Am Soc Hematol Educ Program -- Export Date: 2 January 2019 -- Review -- Source: Scopus C2 - 30504298
Altmetric Score
MSK Authors
  1. Sergio Andres Giralt
    499 Giralt